Partner Content Partner Content Superbugs: Exclusive Interviews Released with ABAC Therapeut... Q&A's Out Ahead of Superbugs 2018
News ADC Therapeutics slumps on cancer drug safety scare Shares in ADC Therapeutics fell more than 50% after a non-Hodgkin lymphoma trial showed more deaths with its Zynlonta drug compared to a control.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
